Frank Mccormick - 26 Dec 2024 Form 4/A - Amendment Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
26 Dec 2024
Net transactions value
$0
Form type
4/A - Amendment
Filing time
08 Jan 2025, 17:43:55 UTC
Date Of Original Report
27 Dec 2024
Previous filing
25 Jun 2024
Next filing
09 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Gift $0 -7,400 -6.2% $0.000000 112,686 26 Dec 2024 Direct
holding BBIO Common Stock 979,979 26 Dec 2024 By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4/A corrects the share holdings in Box 5 of Table I.